ARE BOTH HYDRALAZINE AND ISOSORBIDE DINITRATE NECESSARY TO PROVIDE A MORTALITY BENEFIT IN AFRICAN AMERICAN PATIENTS WITH SYSTOLIC HEART FAILURE?

[...]the combination of both Hyd and ISDN did not afford a mortality benefit compared to either agent alone. [...]the mortality benefit afforded to AA with Hyd-ISDN does not appear to require both agents.

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E1034-E1034
Main Authors: Salamon, Jason N, Mazurek, Jeremy, Zolty, Ronald
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Drug therapy
Heart failure
Internal Medicine
Mortality
Multivariate analysis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]the combination of both Hyd and ISDN did not afford a mortality benefit compared to either agent alone. [...]the mortality benefit afforded to AA with Hyd-ISDN does not appear to require both agents.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)61035-3